{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T07:14:48Z","timestamp":1790234088005,"version":"4.1.0"},"reference-count":64,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,1,15]]},"DOI":"10.1097\/tp.0b013e318236cd1a","type":"journal-article","created":{"date-parts":[[2011,10,20]],"date-time":"2011-10-20T05:18:49Z","timestamp":1319087929000},"page":"17-21","source":"Crossref","is-referenced-by-count":26,"title":["How I Treat Cryptococcosis in Organ Transplant Recipients"],"prefix":"10.1097","volume":"93","author":[{"given":"Nina","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210129","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/QAD.0b013e328322ffac","article-title":"Estimation of the current global burden of cryptococcal meningitis among persons living with HIV\/AIDS.","volume":"23","author":"Park","year":"2009","journal-title":"AIDS"},{"key":"R2-3-20210129","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1399-3062.2006.00149.x","article-title":"Cryptococcosis in liver and kidney transplant recipients receiving anti-thymocyte globulin or alemtuzumab.","volume":"9","author":"Silveira","year":"2007","journal-title":"Transpl Infect Dis"},{"key":"R3-3-20210129","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1086\/598936","article-title":"Cryptococcosis in solid-organ, hematopoietic stem cell, and tissue transplant recipients: Evidence-based evolving trends.","volume":"48","author":"Sun","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R4-3-20210129","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3201\/eid0703.017302","article-title":"Cryptococcus neoformans infection in organ transplant recipients: Variables influencing clinical characteristics and outcome.","volume":"7","author":"Husain","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"R5-3-20210129","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1086\/647948","article-title":"Lipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipients with central nervous system cryptococcosis.","volume":"49","author":"Sun","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R6-3-20210129","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/01.md.0000126760.45299.69","article-title":"Cryptococcus neoformans infection in patients with cirrhosis, including liver transplant candidates.","volume":"83","author":"Singh","year":"2004","journal-title":"Medicine (Baltimore)"},{"key":"R7-3-20210129","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s10096-007-0430-1","article-title":"Disseminated cryptococcosis in HIV-uninfected patients.","volume":"27","author":"Chuang","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R8-3-20210129","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1086\/322597","article-title":"Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy.","volume":"33","author":"Pappas","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R9-3-20210129","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/qjmed\/95.8.511","article-title":"Cryptococcaemia: Clinical features and prognostic factors.","volume":"95","author":"Jean","year":"2002","journal-title":"QJM"},{"key":"R10-3-20210129","doi-asserted-by":"crossref","first-page":"229","DOI":"10.5414\/CNP72229","article-title":"Cryptococcal pleuritis developing in a patient on regular hemodialysis.","volume":"72","author":"Kinjo","year":"2009","journal-title":"Clin Nephrol"},{"key":"R11-3-20210129","doi-asserted-by":"crossref","first-page":"88","DOI":"10.5414\/CNP71088","article-title":"Pulmonary capillary embolism caused by cryptococcemia in a hemodialysis patient.","volume":"71","author":"Eriguchi","year":"2009","journal-title":"Clin Nephrol"},{"key":"R12-3-20210129","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/clinids\/17.4.736","article-title":"Cryptococcal peritonitis: Report of a case developing during continuous ambulatory peritoneal dialysis and review of the literature.","volume":"17","author":"Yinnon","year":"1993","journal-title":"Clin Infect Dis"},{"key":"R13-3-20210129","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1086\/656584","article-title":"Unrecognized pretransplant and donor-derived cryptococcal disease in organ transplant recipients.","volume":"51","author":"Sun","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R14-3-20210129","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0022-3476(78)80433-8","article-title":"Successful renal transplantation after generalized cryptococcosis.","volume":"92","author":"Iitaka","year":"1978","journal-title":"J Pediatr"},{"key":"R15-3-20210129","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/00000658-197511000-00014","article-title":"The incidence and management of pulmonary mycosis in renal allograft patients.","volume":"182","author":"Mills","year":"1975","journal-title":"Ann Surg"},{"key":"R16-3-20210129","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1001\/archinte.1969.00300200114019","article-title":"Successful renal allograft in a patient with pulmonary cryptococcus.","volume":"124","author":"Swenson","year":"1969","journal-title":"Arch Intern Med"},{"key":"R17-3-20210129","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/lt.22024","article-title":"Pretransplant cryptococcosis and outcome after liver transplantation.","volume":"16","author":"Sifri","year":"2010","journal-title":"Liver Transpl"},{"key":"R18-3-20210129","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/lt.22066","article-title":"Solitary pulmonary nodule in the liver transplant candidate: Importance of diagnosis and treatment.","volume":"16","author":"Concejero","year":"2010","journal-title":"Liver Transpl"},{"key":"R19-3-20210129","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/emboj\/19.14.3618","article-title":"Identification and characterization of a highly conserved calcineurin binding protein, CBP1\/calcipressin, in Cryptococcus neoformans.","volume":"19","author":"G\u00f6rlach","year":"2000","journal-title":"EMBO J"},{"key":"R20-3-20210129","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/00007890-197104000-00018","article-title":"Survival of a patient transplanted with a kidney infected with Cryptococcus neoformans.","volume":"11","author":"Ooi","year":"1971","journal-title":"Transplantation"},{"key":"R21-3-20210129","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1093\/cid\/ciq216","article-title":"Transmission of Cryptococcus neoformans by Organ Transplantation.","volume":"52","author":"Baddley","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R23-3-20210129","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/00005792-199605000-00004","article-title":"Fungal infections in lung and heart-lung transplant recipients: Report of 9 cases and review of the literature.","volume":"75","author":"Kanj","year":"1996","journal-title":"Medicine (Baltimore)"},{"key":"R24-3-20210129","first-page":"1898","article-title":"Cryptococcosis in renal transplant recipients.","volume":"24","author":"Shaariah","year":"1992","journal-title":"Transplant Proc"},{"key":"R25-3-20210129","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1086\/524738","article-title":"Pulmonary cryptococcosis in solid organ transplant recipients: Clinical relevance of serum cryptococcal antigen.","volume":"46","author":"Singh","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R26-3-20210129","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1001\/archinte.1975.00330090027003","article-title":"Cryptococcal meningitis: Diagnostic value of cryptococcal antigen in cerebrospinal fluid.","volume":"135","author":"Snow","year":"1975","journal-title":"Arch Intern Med"},{"key":"R27-3-20210129","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1055\/s-2004-824899","article-title":"Pulmonary cryptococcosis.","volume":"25","author":"Lortholary","year":"2004","journal-title":"Semin Respir Crit Care Med"},{"key":"R28-3-20210129","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1034\/j.1600-6143.2002.20701.x","article-title":"Cryptococcosis in organ transplant recipients: An overview.","volume":"2","author":"Vilchez","year":"2002","journal-title":"Am J Transplant"},{"key":"R29-3-20210129","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1378\/chest.115.3.734","article-title":"Pulmonary crytococcosis in patients without HIV infection.","volume":"115","author":"Aberg","year":"1999","journal-title":"Chest"},{"issue":"Suppl 4","key":"R30-3-20210129","doi-asserted-by":"crossref","first-page":"S192","DOI":"10.1111\/j.1600-6143.2009.02911.x","article-title":"Cryptococcosis in solid organ transplant recipients.","volume":"9","author":"Singh","year":"2009","journal-title":"Am J Transplant"},{"key":"R31-3-20210129","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America.","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R32-3-20210129","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1128\/AAC.36.5.977","article-title":"Pharmacologic modulation of interleukin-1 expression by amphotericin B-stimulated human mononuclear cells.","volume":"36","author":"Cleary","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"R33-3-20210129","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1128\/AAC.35.5.796","article-title":"Enhancement of macrophage superoxide anion production by amphotericin B.","volume":"35","author":"Wilson","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"R34-3-20210129","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0008-8749(87)90059-1","article-title":"Parallel inheritance of tissue catalase activity and immunostimulatory action of amphotericin B in inbred mouse strains.","volume":"105","author":"Stein","year":"1987","journal-title":"Cell Immunol"},{"key":"R35-3-20210129","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3109\/08923979109019702","article-title":"Amphotericin B selectively stimulates macrophages from high responder mouse strains.","volume":"13","author":"Wolf","year":"1991","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"R36-3-20210129","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1128\/IAI.73.1.494-503.2005","article-title":"Differences in patterns of infection and inflammation for corticosteroid treatment and chemotherapy in experimental invasive pulmonary aspergillosis.","volume":"73","author":"Balloy","year":"2005","journal-title":"Infect Immun"},{"key":"R37-3-20210129","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1128\/AAC.49.4.1397-1403.2005","article-title":"Differential expression of cytokines and chemokines in human monocytes induced by lipid formulations of amphotericin B.","volume":"49","author":"Simitsopoulou","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"R38-3-20210129","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1439-0507.1995.tb00020.x","article-title":"Infusion-related toxicity of three different amphotericin B formulations and its relation to cytokine plasma levels.","volume":"38","author":"Arning","year":"1995","journal-title":"Mycoses"},{"key":"R39-3-20210129","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1073\/pnas.92.7.2815","article-title":"Endogenously opsonized particles divert prostanoid action from lethal to protective in models of experimental endotoxemia.","volume":"92","author":"Eierman","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R40-3-20210129","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0005-2736(94)90231-3","article-title":"Liposome-complement interactions in rat serum: Implications for liposome survival studies.","volume":"1191","author":"Devine","year":"1994","journal-title":"Biochim Biophys Acta"},{"key":"R41-3-20210129","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1086\/589290","article-title":"Immunocompromised hosts: Immunopharmacology of modern antifungals.","volume":"47","author":"Ben-Ami","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R42-3-20210129","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1128\/AAC.00990-07","article-title":"Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: Correlation with outcome in solid organ transplant recipients with cryptococcosis.","volume":"52","author":"Kontoyiannis","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"R43-3-20210129","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1128\/AAC.40.10.2300","article-title":"Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors.","volume":"40","author":"Sanglard","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"R44-3-20210129","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1091\/mbc.9.2.523","article-title":"Genetic separation of FK506 susceptibility and drug transport in the yeast Pdr5 ATP-binding cassette multidrug resistance transporter.","volume":"2","author":"Egner","year":"1998","journal-title":"Mol Biol Cell"},{"key":"R45-3-20210129","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1086\/374557","article-title":"Voriconazole treatment for less-common, emerging, or refractory fungal infections.","volume":"36","author":"Perfect","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R46-3-20210129","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/515110","article-title":"A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. National Institute of Allergy and Infectious Diseases Mycoses Study Group.","volume":"28","author":"Saag","year":"1999","journal-title":"Clin Infect Dis"},{"key":"R47-3-20210129","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1128\/AAC.01384-07","article-title":"In vitro activity of the new azole isavuconazole (BAL4815) compared with six other antifungal agents against 162 Cryptococcus neoformans isolates from Cuba.","volume":"52","author":"Illnait-Zaragozi","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"R48-3-20210129","doi-asserted-by":"crossref","first-page":"942","DOI":"10.3109\/13693781003690067","article-title":"Antifungal susceptibility, serotyping, and genotyping of clinical Cryptococcus neoformans isolates collected during 18 years in a single institution in Madrid, Spain.","volume":"48","author":"Guinea","year":"2010","journal-title":"Med Mycol"},{"key":"R49-3-20210129","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1086\/430606","article-title":"An immune reconstitution syndrome-like entity associated with Cryptococcus neoformans infections in organ transplant recipients.","volume":"40","author":"Singh","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R50-3-20210129","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1473-3099(07)70085-3","article-title":"Immune reconstitution syndrome associated with opportunistic mycoses.","volume":"7","author":"Singh","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"R51-3-20210129","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/QCO.0b013e32832d7aff","article-title":"Immune reconstitution inflammatory syndrome in non-HIV immunocompromised patients.","volume":"22","author":"Sun","year":"2009","journal-title":"Curr Opin Infect Dis"},{"key":"R52-3-20210129","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/01.tp.0000189713.14993.db","article-title":"Campath-1H induction and the incidence of infectious complications in adult renal transplantation.","volume":"81","author":"Malek","year":"2006","journal-title":"Transplantation"},{"key":"R54-3-20210129","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1111\/j.1600-6143.2007.01994.x","article-title":"Cellulitis revealing a cryptococcosis-related immune reconstitution inflammatory syndrome in a renal allograft recipient.","volume":"7","author":"Lanternier","year":"2007","journal-title":"Am J Transplant"},{"key":"R55-3-20210129","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1473-3099(08)70184-1","article-title":"Tuberculosis-associated immune reconstitution inflammatory syndrome; case definitions for use in resource-limited settings.","volume":"8","author":"Meintjes","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"R56-3-20210129","doi-asserted-by":"crossref","first-page":"e11416","DOI":"10.1371\/journal.pone.0011416","article-title":"Risk factor analyses for immune reconstitution inflammatory syndrome in a randomized study of early vs. deferred ART during an opportunistic infection.","volume":"5","author":"Grant","year":"2010","journal-title":"PLoS One"},{"key":"R57-3-20210129","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.4049\/jimmunol.178.4.2517","article-title":"Glucocorticoid conditioning of myeloid progenitors enhances TLR4 signaling via negative regulation of the phosphatidylinositol 3-kinase-Akt pathway.","volume":"178","author":"Zhang","year":"2007","journal-title":"J Immunol"},{"key":"R58-3-20210129","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/nm1108-1155","article-title":"Graft-versus-host disease: Suppression by statins.","volume":"14","author":"Broady","year":"2008","journal-title":"Nat Med"},{"key":"R59-3-20210129","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00005-009-0038-5","article-title":"Immunomodulation by statins: Mechanisms and potential impact on autoimmune diseases.","volume":"57","author":"Chow","year":"2009","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"R60-3-20210129","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1182\/blood-2008-01-132050","article-title":"The impact of HMG-CoA reductase inhibition on the incidence and severity of graft-versus-host disease in patients with acute leukemia undergoing allogeneic transplantation.","volume":"111","author":"Hamadani","year":"2008","journal-title":"Blood"},{"key":"R61-3-20210129","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1086\/522993","article-title":"A patient with de novo tuberculosis during anti-tumor necrosis factor-alpha therapy illustrating diagnostic pitfalls and paradoxical response to treatment.","volume":"45","author":"Arend","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R62-3-20210129","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1111\/j.1600-6143.2010.03279.x","article-title":"Perioperative infliximab application ameliorates acute rejection associated inflammation after intestinal transplantation.","volume":"10","author":"Pech","year":"2010","journal-title":"Am J Transplant"},{"key":"R63-3-20210129","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/j.1600-6143.2011.03497.x","article-title":"Tumor necrosis factor alpha inhibitors as immunomodulatory antirejection agents after intestinal transplantation.","volume":"11","author":"Gerlach","year":"2011","journal-title":"Am J Transplant"},{"key":"R64-3-20210129","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1097\/01.tp.0000173774.74388.49","article-title":"Antifungal management practices and evolution of infection in organ transplant recipients with C. neoformans infection.","volume":"80","author":"Singh","year":"2005","journal-title":"Transplantation"},{"key":"R65-3-20210129","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1086\/420829","article-title":"Recombinant interferon-gamma 1b as adjunctive therapy for AIDS-related acute cryptococcal meningitis.","volume":"189","author":"Pappas","year":"2004","journal-title":"J Infect Dis"},{"key":"R66-3-20210129","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1111\/j.1600-6143.2010.03094.x","article-title":"Exogenous interferon-gamma immunotherapy for invasive fungal infections in kidney transplant patients.","volume":"10","author":"Armstrong-James","year":"2010","journal-title":"Am J Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00007890-201201150-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:27:46Z","timestamp":1786048066000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007890-201201150-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,15]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0b013e318236cd1a","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1,15]]}}}